Media Centre


IMMY register new lateral flow immunoassay (IgG & IgM) for Coccidioides (Valley Fever)

November 16 2017

IMMY have registered a new lateral flow device (sona™) with the FDA, which delivers a result in only 30 minutes
Read more

Type 2 diabetes: a risk factor for acquisition of and increased mortality from cryptococcal disease

November 02 2017

Type 2 diabetes has recently emerged as a putative risk factor for cryptococcal infections. A recent study in mainland China by Yingfang Li and colleagues reported a cryptococcal disease prevalence of 0.21% (1 in 475) among diabetic hospital patients, suggesting that improved blood glucose control may be important in preventing infection.
Read more

Watch for influenza-associated aspergillosis (IAA) in critically ill patients

October 31 2017

Around 1 in 6 ICU patients with influenza has a co-infection, but fungal co-infections tend to be underdiagnosed despite being associated with poor outcomes. Radiological signs (cavitary lesions, nodules, air-crescent) and galactomannan testing can identify which patients are likely to benefit from antifungal therapy.
Read more

Consider aspergillosis as an alternate diagnosis for smear-negative TB patients

October 24 2017

Overlap in clinical and radiological presentations between tuberculosis (TB) and chronic pulmonary aspergillosis (CPA) makes diagnosis challenging, especially in settings where advanced radiological and laboratory facilities are not available. CPA is likely underdiagnosed in these groups: one recent study of Nigerian TB patients by Rita Oladele and colleagues showed around 19% of HIV negative, smear negative patients had CPA.
Read more

 < 1 2 3 4 >  Last ›